During the past decade, Central Florida Cardiology Group conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Central Florida Cardiology Group" are "Acute Coronary Syndrome" (1 trials), "Coronary Artery Disease" (1 trials), "Influenza, Human" (1 trials), "Myocardial Infarction" (1 trials) and "Myocardial Ischemia" (1 trials). Many other conditions were trialed in "Central Florida Cardiology Group" in a lesser frequency.

Most popular intervention types in "Central Florida Cardiology Group" are "Biological" (2 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "CGT-2168 (clopidogrel 75 mg/omeprazole 20 mg) and aspirin" (1 trials), "CLBS14 (high-dose)" (1 trials), "CLBS14 (low-dose)" (1 trials), "Plavix (clopidogrel 75 mg) and aspirin" (1 trials) and "QIV" (1 trials). Other intervention names were less common.

The vast majority of trials in "Central Florida Cardiology Group" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Central Florida Cardiology Group". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Central Florida Cardiology Group, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Central Florida Cardiology Group, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".